BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

888 related articles for article (PubMed ID: 10620075)

  • 1. Down-regulation of the serum stimulatory components of the insulin-like growth factor (IGF) system (IGF-I, IGF-II, IGF binding protein [BP]-3, and IGFBP-5) in age-related (type II) femoral neck osteoporosis.
    Boonen S; Mohan S; Dequeker J; Aerssens J; Vanderschueren D; Verbeke G; Broos P; Bouillon R; Baylink DJ
    J Bone Miner Res; 1999 Dec; 14(12):2150-8. PubMed ID: 10620075
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy.
    Jehle PM; Ostertag A; Schulten K; Schulz W; Jehle DR; Stracke S; Fiedler R; Deuber HJ; Keller F; Boehm BO; Baylink DJ; Mohan S
    Kidney Int; 2000 Feb; 57(2):423-36. PubMed ID: 10652019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serum levels of insulin-like growth factor system components and relationship to bone metabolism in Type 1 and Type 2 diabetes mellitus patients.
    Jehle PM; Jehle DR; Mohan S; Böhm BO
    J Endocrinol; 1998 Nov; 159(2):297-306. PubMed ID: 9795371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Age-related (type II) femoral neck osteoporosis in men: biochemical evidence for both hypovitaminosis D- and androgen deficiency-induced bone resorption.
    Boonen S; Vanderschueren D; Cheng XG; Verbeke G; Dequeker J; Geusens P; Broos P; Bouillon R
    J Bone Miner Res; 1997 Dec; 12(12):2119-26. PubMed ID: 9421246
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Calciotropic hormones and markers of bone remodeling in age-related (type II) femoral neck osteoporosis: alterations consistent with secondary hyperparathyroidism-induced bone resorption.
    Boonen S; Broos P; Verbeke G; Aerssens J; Van Herck E; Jans I; Dequeker J; Bouillon R
    J Gerontol A Biol Sci Med Sci; 1997 Sep; 52(5):M286-93. PubMed ID: 9310082
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Age-related changes in IGFBP-4 and IGFBP-5 levels in human serum and bone: implications for bone loss with aging.
    Mohan S; Farley JR; Baylink DJ
    Prog Growth Factor Res; 1995; 6(2-4):465-73. PubMed ID: 8817691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The relationship among circulating insulin-like growth factor components, biochemical markers of bone turnover and bone mineral density in postmenopausal women under the age of 60.
    Kim JG; Shin CS; Choi YM; Moon SY; Kim SY; Lee JY
    Clin Endocrinol (Oxf); 1999 Sep; 51(3):301-7. PubMed ID: 10469009
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum insulin-like growth factor-I, insulin-like growth factor binding protein-3, sex steroids, osteocalcin and bone mineral density in male and female rats.
    Fukuda R; Usuki S; Mukai N; Amagai H; Hayashi K; Takamatsu K
    Gynecol Endocrinol; 1998 Oct; 12(5):297-305. PubMed ID: 9859021
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum levels of insulin-like growth factor (IGF); IGF-binding proteins-3, -4, and -5; and their relationships to bone mineral density and the risk of vertebral fractures in postmenopausal women.
    Yamaguchi T; Kanatani M; Yamauchi M; Kaji H; Sugishita T; Baylink DJ; Mohan S; Chihara K; Sugimoto T
    Calcif Tissue Int; 2006 Jan; 78(1):18-24. PubMed ID: 16397738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of insulin-like growth factor (IGF) I, IGF-binding protein (IGFBP)-2, and IGFBP-3 in osteoporotic patients with and without spinal fractures.
    Sugimoto T; Nishiyama K; Kuribayashi F; Chihara K
    J Bone Miner Res; 1997 Aug; 12(8):1272-9. PubMed ID: 9258758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insulin-like growth factor-1 is associated with bone formation markers, PTH and bone mineral density in healthy premenopausal women.
    Adami S; Zivelonghi A; Braga V; Fracassi E; Gatti D; Rossini M; Ulivieri FM; Viapiana O
    Bone; 2010 Jan; 46(1):244-7. PubMed ID: 19853071
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Importance of albumin, 25(OH)-vitamin D and IGFBP-3 as risk factors in elderly women and men with hip fracture.
    Thiébaud D; Burckhardt P; Costanza M; Sloutskis D; Gilliard D; Quinodoz F; Jacquet AF; Burnand B
    Osteoporos Int; 1997; 7(5):457-62. PubMed ID: 9425504
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High serum IGFBP-2 is predictive of increased bone turnover in aging men and women.
    Amin S; Riggs BL; Melton LJ; Achenbach SJ; Atkinson EJ; Khosla S
    J Bone Miner Res; 2007 Jun; 22(6):799-807. PubMed ID: 17352648
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of bone mineral density and turnover in patients with cystic fibrosis: associations between the IGF system and inflammatory cytokines.
    Street ME; Spaggiari C; Ziveri MA; Volta C; Federico G; Baroncelli GI; Bernasconi S; Saggese G
    Horm Res; 2006; 66(4):162-8. PubMed ID: 16804317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone mineral density in femoral neck is positively correlated to circulating insulin-like growth factor (IGF)-I and IGF-binding protein (IGFBP)-3 in Swedish men.
    Gillberg P; Olofsson H; Mallmin H; Blum WF; Ljunghall S; Nilsson AG
    Calcif Tissue Int; 2002 Jan; 70(1):22-9. PubMed ID: 11907704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insulin-like growth factor I is a determinant of hip bone mineral density in men less than 60 years of age: MINOS study.
    Szulc P; Joly-Pharaboz MO; Marchand F; Delmas PD
    Calcif Tissue Int; 2004 Apr; 74(4):322-9. PubMed ID: 15255068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Musculoskeletal effects of the recombinant human IGF-I/IGF binding protein-3 complex in osteoporotic patients with proximal femoral fracture: a double-blind, placebo-controlled pilot study.
    Boonen S; Rosen C; Bouillon R; Sommer A; McKay M; Rosen D; Adams S; Broos P; Lenaerts J; Raus J; Vanderschueren D; Geusens P
    J Clin Endocrinol Metab; 2002 Apr; 87(4):1593-9. PubMed ID: 11932288
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Circulating insulin-like growth factor binding protein-4 (IGFBP-4) is not regulated by parathyroid hormone and vitamin D in vivo: evidence from children with rickets.
    Bereket A; Cesur Y; Özkan B; Adal E; Turan S; Onan SH; Döneray H; Akçay T; Haklar G
    J Clin Res Pediatr Endocrinol; 2010; 2(1):17-20. PubMed ID: 21274331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insulin-like growth factor-I and bone mineral density.
    Collins D; Woods A; Herd R; Blake G; Fogelman I; Wheeler M; Swaminathan R
    Bone; 1998 Jul; 23(1):13-6. PubMed ID: 9662125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Concentration of insulin-like growth factor (IGF)-I in iliac crest bone matrix in premenopausal women with idiopathic osteoporosis.
    Pepene CE; Seck T; Diel I; Minne HW; Ziegler R; Pfeilschifter J
    Exp Clin Endocrinol Diabetes; 2004 Jan; 112(1):38-43. PubMed ID: 14758570
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.